Targeting the adaptability of heterogeneous aneuploids

Cell

Volumn 160, Issue 4, 2015, Pages 771-784

  Chen, Guangbo ^a,b   Mulla, Wahid A ^a,b   Kucharavy, Andrei ^a,c   Tsai, Hung Ji ^a   Rubinstein, Boris ^a   Conkright, Juliana ^a   McCroskey, Scott ^a   Bradford, William D ^a   Weems, Lauren ^a   Haug, Jeff S ^a   Seidel, Chris W ^a   Berman, Judith ^d   Li, Rong ^a,b  

^a STOWERS INSTITUTE FOR MEDICAL RESEARCH   (United States)

^b UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^c SORBONNE UNIVERSITÉ   (France)

^d TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; ERLOTINIB; FLUCONAZOLE; GEFITINIB; HYGROMYCIN B; PYRROLE DERIVATIVE; RADICICOL; ANTIFUNGAL AGENT; ANTINEOPLASTIC AGENT; CAMPTOTHECIN; IRINOTECAN;

ANEUPLOIDY; ARTICLE; BREAST CANCER; CANDIDA ALBICANS; CELL POPULATION; CHROMOSOME; CONTROLLED STUDY; DIPLOIDY; DNA CONTENT; GENETIC HETEROGENEITY; GLIOBLASTOMA; GROWTH INHIBITION; HUMAN; HUMAN CELL; KARYOTYPE; MOLECULAR EVOLUTION; NONHUMAN; PHARMACOGENOMICS; PHENOTYPIC VARIATION; PRIORITY JOURNAL; SACCHAROMYCES CEREVISIAE; SELECTIVE SWEEP; STOICHIOMETRY; STRESS; TETRAPLOIDY; TRIPLOIDY; TUMOR CELL LINE; ANALOGS AND DERIVATIVES; ANTAGONISTS AND INHIBITORS; ANTIFUNGAL RESISTANCE; DRUG EFFECTS; DRUG RESISTANCE; GENETICS; METABOLISM;

CANDIDA ALBICANS; FUNGI; SACCHAROMYCETALES;

ANEUPLOIDY; ANTIFUNGAL AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CAMPTOTHECIN; CANDIDA ALBICANS; CELL LINE, TUMOR; DRUG RESISTANCE, FUNGAL; DRUG RESISTANCE, NEOPLASM; FLUCONAZOLE; GLIOBLASTOMA; HUMANS; HYGROMYCIN B; RECEPTOR, EPIDERMAL GROWTH FACTOR; SACCHAROMYCES CEREVISIAE;

EID: 84922718815     PISSN: 00928674     EISSN: 10974172     Source Type: Journal    
DOI: 10.1016/j.cell.2015.01.026     Document Type: Article

References (64)

1. J. Barretina, G. Caponigro, N. Stransky, K. Venkatesan, A.A. Margolin, S. Kim, C.J. Wilson, J. Lehár, G.V. Kryukov, and D. Sonkin The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity Nature 483 2012 603 607
2. J. Bean, C. Brennan, J.-Y. Shih, G. Riely, A. Viale, L. Wang, D. Chitale, N. Motoi, J. Szoke, and S. Broderick MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib Proc. Natl. Acad. Sci. USA 104 2007 20932 20937
3. R. Beroukhim, C.H. Mermel, D. Porter, G. Wei, S. Raychaudhuri, J. Donovan, J. Barretina, J.S. Boehm, J. Dobson, and M. Urashima The landscape of somatic copy-number alteration across human cancers Nature 463 2010 899 905
4. A.R. Borneman, B.A. Desany, D. Riches, J.P. Affourtit, A.H. Forgan, I.S. Pretorius, M. Egholm, and P.J. Chambers Whole-genome comparison reveals novel genetic elements that characterize the genome of industrial strains of Saccharomyces cerevisiae PLoS Genet. 7 2011 e1001287
5. M.A. Borovinskaya, S. Shoji, K. Fredrick, and J.H.D. Cate Structural basis for hygromycin B inhibition of protein biosynthesis RNA 14 2008 1590 1599
6. M. Bredel, D.M. Scholtens, G.R. Harsh, C. Bredel, J.P. Chandler, J.J. Renfrow, A.K. Yadav, H. Vogel, A.C. Scheck, R. Tibshirani, and B.I. Sikic A network model of a cooperative genetic landscape in brain tumors JAMA 302 2009 261 275
7. R.A. Burrell, N. McGranahan, J. Bartek, and C. Swanton The causes and consequences of genetic heterogeneity in cancer evolution Nature 501 2013 338 345
8. J. St Charles, M.L. Hamilton, and T.D. Petes Meiotic chromosome segregation in triploid strains of Saccharomyces cerevisiae Genetics 186 2010 537 550
9. G. Chen, W.D. Bradford, C.W. Seidel, and R. Li Hsp90 stress potentiates rapid cellular adaptation through induction of aneuploidy Nature 482 2012 246 250
10. G. Chen, B. Rubinstein, and R. Li Whole chromosome aneuploidy: big mutations drive adaptation by phenotypic leap Bioessays 34 2012 893 900
11. T. Davoli, A.W. Xu, K.E. Mengwasser, L.M. Sack, J.C. Yoon, P.J. Park, and S.J. Elledge Cumulative haploinsufficiency and triplosensitivity drive aneuploidy patterns and shape the cancer genome Cell 155 2013 948 962
12. M. Gerlinger, A.J. Rowan, S. Horswell, J. Larkin, D. Endesfelder, E. Gronroos, P. Martinez, N. Matthews, A. Stewart, and P. Tarpey Intratumor heterogeneity and branched evolution revealed by multiregion sequencing N. Engl. J. Med. 366 2012 883 892
13. S. Ghaemmaghami, W.-K. Huh, K. Bower, R.W. Howson, A. Belle, N. Dephoure, E.K. O'Shea, and J.S. Weissman Global analysis of protein expression in yeast Nature 425 2003 737 741
14. B.D. Harrison, J. Hashemi, M. Bibi, R. Pulver, D. Bavli, Y. Nahmias, M. Wellington, G. Sapiro, and J. Berman A tetraploid intermediate precedes aneuploid formation in yeasts exposed to fluconazole PLoS Biol. 12 2014 e1001815
15. L.M. Heiser, A. Sadanandam, W.-L. Kuo, S.C. Benz, T.C. Goldstein, S. Ng, W.J. Gibb, N.J. Wang, S. Ziyad, and F. Tong Subtype and pathway specific responses to anticancer compounds in breast cancer Proc. Natl. Acad. Sci. USA 109 2012 2724 2729
16. C.H. Ho, L. Magtanong, S.L. Barker, D. Gresham, S. Nishimura, P. Natarajan, J.L.Y. Koh, J. Porter, C.A. Gray, and R.J. Andersen A molecular barcoded yeast ORF library enables mode-of-action analysis of bioactive compounds Nat. Biotechnol. 27 2009 369 377
17. A.J. Holland, and D.W. Cleveland Boveri revisited: chromosomal instability, aneuploidy and tumorigenesis Nat. Rev. Mol. Cell Biol. 10 2009 478 487
18. T.R. Hughes, C.J. Roberts, H. Dai, A.R. Jones, M.R. Meyer, D. Slade, J. Burchard, S. Dow, T.R. Ward, and M.J. Kidd Widespread aneuploidy revealed by DNA microarray expression profiling Nat. Genet. 25 2000 333 337
19. J.J. Infante, K.M. Dombek, L. Rebordinos, J.M. Cantoral, and E.T. Young Genome-wide amplifications caused by chromosomal rearrangements play a major role in the adaptive evolution of natural yeast Genetics 165 2003 1745 1759
20. L. Jones, G. Wei, S. Sevcikova, V. Phan, S. Jain, A. Shieh, J.C.Y. Wong, M. Li, J. Dubansky, and M.L. Maunakea Gain of MYC underlies recurrent trisomy of the MYC chromosome in acute promyelocytic leukemia J. Exp. Med. 207 2010 2581 2594
21. W.G. Kaelin Jr. The concept of synthetic lethality in the context of anticancer therapy Nat. Rev. Cancer 5 2005 689 698
22. D.J. Kvitek, J.L. Will, and A.P. Gasch Variations in stress sensitivity and genomic expression in diverse S. cerevisiae isolates PLoS Genet. 4 2008 e1000223
23. A.J.X. Lee, D. Endesfelder, A.J. Rowan, A. Walther, N.J. Birkbak, P.A. Futreal, J. Downward, Z. Szallasi, I.P.M. Tomlinson, and M. Howell Chromosomal instability confers intrinsic multidrug resistance Cancer Res. 71 2011 1858 1870
24. P. Leprohon, D. Légaré, F. Raymond, É. Madore, G. Hardiman, J. Corbeil, and M. Ouellette Gene expression modulation is associated with gene amplification, supernumerary chromosomes and chromosome loss in antimony-resistant Leishmania infantum Nucleic Acids Res. 37 2009 1387 1399
25. R.C. Lewontin The units of selection Annu. Rev. Ecol. Syst. 1 1970 1 18
26. M.S. Llewellyn, J.B. Rivett-Carnac, S. Fitzpatrick, M.D. Lewis, M. Yeo, M.W. Gaunt, and M.A. Miles Extraordinary Trypanosoma cruzi diversity within single mammalian reservoir hosts implies a mechanism of diversifying selection Int. J. Parasitol. 41 2011 609 614
27. J. Luo, M.J. Emanuele, D. Li, C.J. Creighton, M.R. Schlabach, T.F. Westbrook, K.-K. Wong, and S.J. Elledge A genome-wide RNAi screen identifies multiple synthetic lethal interactions with the Ras oncogene Cell 137 2009 835 848
28. C.C. Maley, P.C. Galipeau, J.C. Finley, V.J. Wongsurawat, X. Li, C.A. Sanchez, T.G. Paulson, P.L. Blount, R.-A. Risques, P.S. Rabinovitch, and B.J. Reid Genetic clonal diversity predicts progression to esophageal adenocarcinoma Nat. Genet. 38 2006 468 473
29. A. Mannaert, T. Downing, H. Imamura, and J.-C. Dujardin Adaptive mechanisms in pathogens: universal aneuploidy in Leishmania Trends Parasitol. 28 2012 370 376
30. P. Marichal, H. Vanden Bossche, F.C. Odds, G. Nobels, D.W. Warnock, V. Timmerman, C. Van Broeckhoven, S. Fay, and P. Mose-Larsen Molecular biological characterization of an azole-resistant Candida glabrata isolate Antimicrob. Agents Chemother. 41 1997 2229 2237
31. K.A. Marr, T.C. White, J.-A.H. van Burik, and R.A. Bowden Development of fluconazole resistance in Candida albicans causing disseminated infection in a patient undergoing marrow transplantation Clin. Infect. Dis. 25 1997 908 910
32. N. McGranahan, R.A. Burrell, D. Endesfelder, M.R. Novelli, and C. Swanton Cancer chromosomal instability: therapeutic and diagnostic challenges EMBO Rep. 13 2012 528 538
33. L.M.F. Merlo, J.W. Pepper, B.J. Reid, and C.C. Maley Cancer as an evolutionary and ecological process Nat. Rev. Cancer 6 2006 924 935
34. T.A. Minning, D.B. Weatherly, S. Flibotte, and R.L. Tarleton Widespread, focal copy number variations (CNV) and whole chromosome aneuploidies in Trypanosoma cruzi strains revealed by array comparative genomic hybridization BMC Genomics 12 2011 139
35. Mitelman, F., Johansson, B., and Mertens, F. (eds.) (2012). Mitelman Database of Chromosome Aberrations and Gene Fusions in Cancer. http://cgap.nci.nih.gov/Chromosomes/Mitelman.
36. N. Navin, J. Kendall, J. Troge, P. Andrews, L. Rodgers, J. McIndoo, K. Cook, A. Stepansky, D. Levy, and D. Esposito Tumour evolution inferred by single-cell sequencing Nature 472 2011 90 94
37. T.C.G.A.R. Network Cancer Genome Atlas Research Network Comprehensive genomic characterization defines human glioblastoma genes and core pathways Nature 455 2008 1061 1068
38. A.P. Ng, C.D. Hyland, D. Metcalf, C.L. Carmichael, S.J. Loughran, L. Di Rago, B.T. Kile, and W.S. Alexander Trisomy of Erg is required for myeloproliferation in a mouse model of Down syndrome Blood 115 2010 3966 3969
39. M. Ni, M. Feretzaki, W. Li, A. Floyd-Averette, P. Mieczkowski, F.S. Dietrich, and J. Heitman Unisexual and heterosexual meiotic reproduction generate aneuploidy and phenotypic diversity de novo in the yeast Cryptococcus neoformans PLoS Biol. 11 2013 e1001653
40. I. Okoli, J.J. Coleman, E. Tempakakis, W.F. An, E. Holson, F. Wagner, A.L. Conery, J. Larkins-Ford, G. Wu, and A. Stern Identification of antifungal compounds active against Candida albicans using an improved high-throughput Caenorhabditis elegans assay PLoS ONE 4 2009 e7025
41. A.B. Oromendia, and A. Amon Aneuploidy: implications for protein homeostasis and disease Dis. Model. Mech. 7 2014 15 20
42. A.B. Oromendia, S.E. Dodgson, and A. Amon Aneuploidy causes proteotoxic stress in yeast Genes Dev. 26 2012 2696 2708
43. N. Pavelka, G. Rancati, J. Zhu, W.D. Bradford, A. Saraf, L. Florens, B.W. Sanderson, G.L. Hattem, and R. Li Aneuploidy confers quantitative proteome changes and phenotypic variation in budding yeast Nature 468 2010 321 325
44. G. Rancati, N. Pavelka, B. Fleharty, A. Noll, R. Trimble, K. Walton, A. Perera, K. Staehling-Hampton, C.W. Seidel, and R. Li Aneuploidy underlies rapid adaptive evolution of yeast cells deprived of a conserved cytokinesis motor Cell 135 2008 879 893
45. D. Sareen, E. McMillan, A.D. Ebert, B.C. Shelley, J.A. Johnson, L.F. Meisner, and C.N. Svendsen Chromosome 7 and 19 trisomy in cultured human neural progenitor cells PLoS ONE 4 2009 e7630
46. A. Selmecki, A. Forche, and J. Berman Aneuploidy and isochromosome formation in drug-resistant Candida albicans Science 313 2006 367 370
47. A. Selmecki, M. Gerami-Nejad, C. Paulson, A. Forche, and J. Berman An isochromosome confers drug resistance in vivo by amplification of two genes, ERG11 and TAC1 Mol. Microbiol. 68 2008 624 641
48. A.M. Selmecki, K. Dulmage, L.E. Cowen, J.B. Anderson, and J. Berman Acquisition of aneuploidy provides increased fitness during the evolution of antifungal drug resistance PLoS Genet. 5 2009 e1000705
49. A. Singh, D. Ursic, and J. Davies Phenotypic suppression and misreading Saccharomyces cerevisiae Nature 277 1979 146 148
50. E. Sionov, H. Lee, Y.C. Chang, and K.J. Kwon-Chung Cryptococcus neoformans overcomes stress of azole drugs by formation of disomy in specific multiple chromosomes PLoS Pathog. 6 2010 e1000848
51. T.C. Smith, A.W. Kinkel, C.M. Gryczko, and J.R. Goulet Absorption of pyrvinium pamoate Clin. Pharmacol. Ther. 19 1976 802 806
52. R. Sotillo, E. Hernando, E. Díaz-Rodríguez, J. Teruya-Feldstein, C. Cordón-Cardo, S.W. Lowe, and R. Benezra Mad2 overexpression promotes aneuploidy and tumorigenesis in mice Cancer Cell 11 2007 9 23
53. R. Sotillo, J.-M. Schvartzman, N.D. Socci, and R. Benezra Mad2-induced chromosome instability leads to lung tumour relapse after oncogene withdrawal Nature 464 2010 436 440
54. A. Sottoriva, I. Spiteri, S.G.M. Piccirillo, A. Touloumis, V.P. Collins, J.C. Marioni, C. Curtis, C. Watts, and S. Tavaré Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics Proc. Natl. Acad. Sci. USA 110 2013 4009 4014
55. M. Spitzer, E. Griffiths, K.M. Blakely, J. Wildenhain, L. Ejim, L. Rossi, G. De Pascale, J. Curak, E. Brown, M. Tyers, and G.D. Wright Cross-species discovery of syncretic drug combinations that potentiate the antifungal fluconazole Mol. Syst. Biol. 7 2011 499
56. M. Taipale, D.F. Jarosz, and S. Lindquist HSP90 at the hub of protein homeostasis: emerging mechanistic insights Nat. Rev. Mol. Cell Biol. 11 2010 515 528
57. Y.-C. Tang, B.R. Williams, J.J. Siegel, and A. Amon Identification of aneuploidy-selective antiproliferation compounds Cell 144 2011 499 512
58. T.E. Taylor, F.B. Furnari, and W.K. Cavenee Targeting EGFR for treatment of glioblastoma: molecular basis to overcome resistance Curr. Cancer Drug Targets 12 2012 197 209
59. E.M. Torres, T. Sokolsky, C.M. Tucker, L.Y. Chan, M. Boselli, M.J. Dunham, and A. Amon Effects of aneuploidy on cellular physiology and cell division in haploid yeast Science 317 2007 916 924
60. J.-M. Ubeda, D. Légaré, F. Raymond, A.A. Ouameur, S. Boisvert, P. Rigault, J. Corbeil, M.J. Tremblay, M. Olivier, B. Papadopoulou, and M. Ouellette Modulation of gene expression in drug resistant Leishmania is associated with gene amplification, gene deletion and chromosome aneuploidy Genome Biol. 9 2008 R115
61. Y. Wang, J. Waters, M.L. Leung, A. Unruh, W. Roh, X. Shi, K. Chen, P. Scheet, S. Vattathil, and H. Liang Clonal evolution in breast cancer revealed by single nucleus genome sequencing Nature 512 2014 155 160
62. B.A.A. Weaver, A.D. Silk, C. Montagna, P. Verdier-Pinard, and D.W. Cleveland Aneuploidy acts both oncogenically and as a tumor suppressor Cancer Cell 11 2007 25 36
63. D.L. Wheeler, E.F. Dunn, and P.M. Harari Understanding resistance to EGFR inhibitors-impact on future treatment strategies. Nature reviews Clin. Oncol. 7 2010 493 507
64. J. Zhu, N. Pavelka, W.D. Bradford, G. Rancati, and R. Li Karyotypic determinants of chromosome instability in aneuploid budding yeast PLoS Genet. 8 2012 e1002719